2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review

Prostate cancer remains the second most common cancer among men. Screening is gaining acceptance, likely reducing mortality at the cost of overdiagnosis and overtreatment. Increasing use of magnetic resonance imaging and biomarkers may mitigate some of the negative consequences of screening. Prostat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European urology Jg. 84; H. 2; S. 191 - 206
Hauptverfasser:	Bergengren, Oskar, Pekala, Kelly R., Matsoukas, Konstantina, Fainberg, Jonathan, Mungovan, Sean F., Bratt, Ola, Bray, Freddie, Brawley, Otis, Luckenbaugh, Amy N., Mucci, Lorelei, Morgan, Todd M., Carlsson, Sigrid V.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland Elsevier B.V 01.08.2023
Schlagworte:	Epidemiology Humans Male Nephrology Njurmedicin Prostate - pathology Prostate cancer Prostate-Specific Antigen Prostatic Neoplasms - diagnosis Prostatic Neoplasms - epidemiology Prostatic Neoplasms - pathology Retrospective Studies Risk Factors Screening Screening Prostate cancer Epidemiology Risk factors
ISSN:	0302-2838, 1873-7560, 1873-7560
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!